Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

已收盘 05-09 16:00:00 EDT

5.10

+0.23

+4.72%

盘后5.20

+0.10+1.96%

19:51 EDT

最高5.35	最低4.82	成交量187.77万
今开4.86	昨收4.87	日振幅10.88%
总市值4.65亿	流通市值2.57亿	总股本9,114万
成交额946.45万	换手率3.73%	流通股本5,038万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":5.1,"timestamp":1715284800000,"preClose":4.87,"halted":0,"volume":1877687,"hourTrading":{"tag":"盘后","latestPrice":5.2,"preClose":5.1,"latestTime":"19:51 EDT","volume":8788,"amount":44854.26,"timestamp":1715298669446},"delay":0,"floatShares":50384965,"shares":91141374,"eps":-1.773906,"marketStatus":"已收盘","marketStatusCode":5,"change":0.23,"latestTime":"05-09 16:00:00 EDT","open":4.86,"high":5.35,"low":4.82,"amount":9464533.898736,"amplitude":0.10883,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.773906,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"listingDate":1595563200000,"adjPreClose":4.87,"preHourTrading":{"tag":"盘前","latestPrice":4.85,"preClose":4.87,"latestTime":"09:29 EDT","volume":555,"amount":2696.10009,"timestamp":1715261340409},"postHourTrading":{"tag":"盘后","latestPrice":5.2,"preClose":5.1,"latestTime":"19:51 EDT","volume":8788,"amount":44854.26,"timestamp":1715298669446},"volumeRatio":1.014475},"requestUrl":"/m/hq/s/ANNX","defaultTab":"news","newsList":[{"id":"2434854045","title":"Annexon, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854045","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434854045?lang=zh_cn&edition=full","pubTime":"2024-05-10 01:40","pubTimestamp":1715276448,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日01时40分，Annexon, Inc.股票出现波动，股价大幅拉升5.13%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。公司的候选产品包括治疗自身免疫和神经退行性疾病的 ANX005，治疗眼科神经退行性疾病的 ANX007，口服小分子药物 ANX1502 以及治疗全身性自身免疫疾病的 ANX009。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100140487a590744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100140487a590744&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432908996","title":"Annexon, Inc.盘中异动 早盘股价大涨5.15%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908996","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432908996?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:31","pubTimestamp":1714743064,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时31分，Annexon, Inc.股票出现波动，股价大幅上涨5.15%。截至发稿，该股报4.90美元/股，成交量6.9241万股，换手率0.08%，振幅1.72%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213105861ead22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213105861ead22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432794699","title":"Annexon Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432794699","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432794699?lang=zh_cn&edition=full","pubTime":"2024-05-03 20:25","pubTimestamp":1714739116,"startTime":"0","endTime":"0","summary":"   * Annexon Inc    预计在5月6日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 Annexon Inc 每股亏损 34 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 8 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Annexon Inc 的 12 个月目标价中位数为 12.00 美元，高于其最新收盘价 4.66 美元。5月3日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432503606","title":"Annexon, Inc.盘中异动 早盘股价大涨5.05%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432503606","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432503606?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:52","pubTimestamp":1714571538,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时52分，Annexon, Inc.股票出现异动，股价快速拉升5.05%。截至发稿，该股报4.78美元/股，成交量5.4904万股，换手率0.06%，振幅3.96%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012152197a57dc17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012152197a57dc17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432837439","title":"Annexon, Inc.盘中异动 股价大跌5.32%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432837439","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432837439?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:01","pubTimestamp":1714492903,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日00时01分，Annexon, Inc.股票出现波动，股价急速下跌5.32%。截至发稿，该股报4.45美元/股，成交量93.169万股，换手率1.03%，振幅5.96%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501000144861ea779&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501000144861ea779&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430234346","title":"Annexon, Inc.盘中异动 急速上涨5.17%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430234346","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430234346?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:56","pubTimestamp":1714064161,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日00时56分，Annexon, Inc.股票出现波动，股价急速上涨5.17%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。消息层面，截至00时56分，《坎托菲茨杰拉德公司：重申Annexon增持评级。》资讯为影响Annexon, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426005601792382dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426005601792382dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429638424","title":"坎托菲茨杰拉德公司：重申Annexon(ANNX.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429638424","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429638424?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:05","pubTimestamp":1713963954,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Annexon(ANNX.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404242105578b4f034d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404242105578b4f034d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428658665","title":"Annexon, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428658665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428658665?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:04","pubTimestamp":1713539044,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时04分，Annexon, Inc.股票出现异动，股价大幅拉升5.18%。截至发稿，该股报4.67美元/股，成交量27.8426万股，换手率0.31%，振幅8.56%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923040487e822a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923040487e822a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427687825","title":"Annexon, Inc.盘中异动 股价大跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427687825","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427687825?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:56","pubTimestamp":1713275793,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时56分，Annexon, Inc.股票出现异动，股价快速下挫5.75%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621563487e80fc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621563487e80fc5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427998001","title":"Annexon, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427998001","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427998001?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:07","pubTimestamp":1713190063,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时07分，Annexon, Inc.股票出现波动，股价急速跳水5.02%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415220744861e5d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415220744861e5d1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426250515","title":"Annexon, Inc.盘中异动 早盘股价大涨5.02%报6.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426250515","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426250515?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:37","pubTimestamp":1712842643,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时37分，Annexon, Inc.股票出现异动，股价快速上涨5.02%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。该信息摘要如下：Needham：重申Annexon评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121372387e7fa32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121372387e7fa32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426253622","title":"Needham：重申Annexon(ANNX.US)评级，由买入调整至买入评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426253622","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426253622?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:25","pubTimestamp":1712834757,"startTime":"0","endTime":"0","summary":"Needham：重申Annexon(ANNX.US)评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119260087676660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119260087676660&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426445670","title":"Annexon, Inc.盘中异动 下午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426445670","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426445670?lang=zh_cn&edition=full","pubTime":"2024-04-11 01:40","pubTimestamp":1712770801,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日01时40分，Annexon, Inc.股票出现异动，股价快速下挫5.14%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411014002791fb160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411014002791fb160&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425291510","title":"Annexon, Inc.盘中异动 大幅下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425291510","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425291510?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:58","pubTimestamp":1712584726,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时58分，Annexon, Inc.股票出现异动，股价急速下挫5.56%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408215846861e3f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408215846861e3f05&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425563031","title":"Annexon, Inc.盘中异动 急速下跌5.02%报6.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425563031","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425563031?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:40","pubTimestamp":1712324408,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时40分，Annexon, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报6.06美元/股，成交量6.2869万股，换手率0.07%，振幅3.45%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405214008861e38b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405214008861e38b1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422990643","title":"Annexon, Inc.盘中异动 早盘大幅上涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422990643","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422990643?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:31","pubTimestamp":1711546316,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时31分，Annexon, Inc.股票出现异动，股价快速上涨6.54%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721315687bc7bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721315687bc7bd5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422548785","title":"Annexon, Inc.盘中异动 早盘大幅上涨5.00%报7.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422548785","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422548785?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373474,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Annexon, Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报7.14美元/股，成交量4.3945万股，换手率0.06%，振幅1.03%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213114861e0da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213114861e0da1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421075588","title":"Annexon, Inc.盘中异动 下午盘股价大涨5.09%报6.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421075588","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421075588?lang=zh_cn&edition=full","pubTime":"2024-03-22 03:05","pubTimestamp":1711047924,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日03时05分，Annexon, Inc.股票出现异动，股价快速上涨5.09%。截至发稿，该股报6.19美元/股，成交量110.144万股，换手率1.41%，振幅7.05%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322030524861e02cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322030524861e02cb&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com","stockEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":-0.195},{"period":"3month","weight":-0.0897},{"period":"6month","weight":1.2918},{"period":"1year","weight":-0.1129},{"period":"ytd","weight":0.0727}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.043018},{"month":2,"riseRate":0.5,"avgChangeRate":0.014392},{"month":3,"riseRate":0.25,"avgChangeRate":-0.117935},{"month":4,"riseRate":0.25,"avgChangeRate":-0.084387},{"month":5,"riseRate":0.75,"avgChangeRate":-0.018742},{"month":6,"riseRate":1,"avgChangeRate":0.147903},{"month":7,"riseRate":0.333333,"avgChangeRate":0.081537},{"month":8,"riseRate":0.5,"avgChangeRate":0.025093},{"month":9,"riseRate":0.75,"avgChangeRate":0.068201},{"month":10,"riseRate":0,"avgChangeRate":-0.174969},{"month":11,"riseRate":0.75,"avgChangeRate":0.099167},{"month":12,"riseRate":0.5,"avgChangeRate":0.128325}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}